FDA holds hearing on psychedelic drugs: 5 things to know
The FDA held a public hearing Sept. 14 on the potential future therapeutic use of psychedelic drugs, gathering input on issues that could shape how health systems eventually deliver this care, from provider credentialing to patient safety protocols. Here are five things to know: The post FDA holds hearing on psychedelic drugs: 5 things to know appeared first on Becker's Hospital Review | Healthcare News & Analysis.
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.